Bosch expands pharmaceutical portfolio
New solutions for the packaging process.
Bosch Packaging Technology has expanded its expertise in the nonaseptic packaging process for pharmaceuticals. Following the introduction of the Sigpack TTMP topload cartoner for pharmaceutical products, the company has added two further machines to its portfolio: the Sigpack VPF vertical flat pouch machine and the horizontal flow wrapping machine Sigpack HML. “Our new machines ideally complement the portfolio of Bosch Packaging Technology. We offer our customers from the pharmaceutical industry reliable and efficient solutions from a single source that can cover the entire production and packaging process,” says Dr Christian Walti, general manager at the Bosch Packaging Technology site in Beringen.
New powder solution offers high flexibility
The new vertical flat pouch machine Sigpack VPF was developed especially for the packaging of powders. Pain killers in powder form are amongst the products typically filled into sachets. Thanks to the innovative sealing technology from Bosch, the machine produces hermetically sealed packages, which safely protect the product. The VPF allows manufacturers to flexibly expand their sachet production by up to twelve lanes. The pouch size can also be quickly and easily adapted according to customer requirements. Thanks to the high dosing accuracy and excellent sealing properties, the machine can produce and fill up to 1 500 sachets per minute precisely and at the highest quality.
In September 2016, the Sigpack VPF received the German Packaging Award from the German Packaging Institute (DVI) in the category packaging machinery.
Compact horizontal flow wrapping machine for hermetic packaging
Bosch further extends its portfolio by a compact horizontal flow wrapping machine, which can either be loaded independently or integrated seamlessly into a complete line. The Sigpack HMUL or HML is available either with ultrasonic or heat sealing technology. “The new flow wrapping machine achieves an output of between 200 and 350 products per minute and is suited for the hermetic packaging of various pharmaceutical products such as vial cards or inhalers. The open machine design enables a quick line clearance, thus ensuring high process safety,” says Daniel Bossel, head of product management at Bosch Packaging Technology.
Flexible solutions for complete lines from a single source
With the expanded machine portfolio, Bosch now offers packaging solutions for every production step from a single source – for example for the treatment of diabetes. Insulin can be produced with bioreactors from Bosch, subsequently filled into cartridges and assembled to insulin pens on further Bosch equipment. CIP/SIP cleaning systems and sterilization equipment can also be integrated into the production process. With the new machine range, manufacturers now also have the possibility to hermetically package the insulin pens into flow wraps. End-of-line solutions such as the Sigpack TTMP cartoner round off Bosch’s line competence. “The modular design of our machines enables manufacturers to individually equip their production lines and add further Bosch equipment. For instance, serialization solutions make each step traceable – from the single pack right through to pallets,” explains Walti. “This way, our customers receive a consistent, user-friendly concept for their entire packaging process."
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance